Citius Pharmaceuticals, Inc. (CTXR) › Shareholders' EquityCitius Pharmaceuticals, Inc. (CTXR) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2010: $2.5K2011: -$1.06M2012: -$1.61M2013: -$2.90M2014: -$741.9K2015: -$635.2K2016: $16.77M2017: $21.95M2018: $30.64M2019: $27.15M2020: $33.67M2021: $132.18M2022: $102.83M2023: $90.83M2024: $70.08M2025: $67.55M$67.55M2010Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$67.55M-3.6%2024$70.08M-22.8%2023$90.83M-11.7%2022$102.83M-22.2%2021$132.18M+292.6%2020$33.67M+24.0%2019$27.15M-11.4%2018$30.64M+39.6%2017$21.95M+30.9%2016$16.77M+2739.5%2015-$635.2K+14.4%2014-$741.9K+74.4%2013-$2.90M-79.8%2012-$1.61M-51.6%2011-$1.06M-42673.0%2010$2.5K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share